Nukkleus Inc (NUKKW) - Net Assets
Based on the latest financial reports, Nukkleus Inc (NUKKW) has net assets worth $-30.42 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.29 Million) and total liabilities ($43.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nukkleus Inc (NUKKW) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-30.42 Million |
| % of Total Assets | -228.91% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 69.14 |
Nukkleus Inc - Net Assets Trend (2013–2024)
This chart illustrates how Nukkleus Inc's net assets have evolved over time, based on quarterly financial data. Also explore Nukkleus Inc assets under control for the complete picture of this company's asset base.
Annual Net Assets for Nukkleus Inc (2013–2024)
The table below shows the annual net assets of Nukkleus Inc from 2013 to 2024. For live valuation and market cap data, see market cap of Nukkleus Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | $-7.10 Million | -165.18% |
| 2023-09-30 | $10.89 Million | 0.00% |
| 2022-09-30 | $10.89 Million | -9.41% |
| 2021-09-30 | $12.02 Million | +962.23% |
| 2020-09-30 | $-1.39 Million | -7.77% |
| 2019-09-30 | $-1.29 Million | -129.56% |
| 2018-09-30 | $-563.53K | -60.39% |
| 2017-09-30 | $-351.35K | -48.64% |
| 2016-09-30 | $-236.38K | -14165.30% |
| 2014-09-30 | $-1.66K | -108.65% |
| 2013-09-30 | $19.15K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nukkleus Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4026510300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $209.00 | % |
| Other Comprehensive Income | $-145.00K | % |
| Other Components | $33.33 Million | % |
| Total Equity | $-7.10 Million | 100.00% |
Nukkleus Inc Competitors by Market Cap
The table below lists competitors of Nukkleus Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ordinary Fully Paid Deferred Settlement
AU:TX3DA
|
$1.13K |
|
Ordinary Fully Paid Deferred Settlement
AU:MKLDB
|
$1.22K |
|
BONAS IMPORT EXPORT S.A.
RO:BONA
|
$1.24K |
|
Fox Marble Holdings PLC
LSE:FOX
|
$1.27K |
|
WARABA GOLD LTD.
F:ZE0
|
$1.05K |
|
LD + HOUSES PCL FGN BA 1
F:LHOG
|
$988.96 |
|
Carzo Holdings Bhd
KLSE:03048
|
$958.49 |
|
Invesque Inc
TO:IVQ
|
$956.23 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nukkleus Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 10,890,580 to -7,098,000, a change of -17,988,580 (-165.2%).
- Net loss of 8,519,000 reduced equity.
- Other comprehensive income decreased equity by 203,219.
- Other factors decreased equity by 9,266,361.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-8.52 Million | -120.02% |
| Other Comprehensive Income | $-203.22K | -2.86% |
| Other Changes | $-9.27 Million | -130.55% |
| Total Change | $- | -165.18% |
Book Value vs Market Value Analysis
This analysis compares Nukkleus Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-09-30 | $0.00 | $0.12 | x |
| 2014-09-30 | $0.00 | $0.12 | x |
| 2015-09-30 | $0.00 | $0.12 | x |
| 2016-09-30 | $0.00 | $0.12 | x |
| 2017-09-30 | $0.00 | $0.12 | x |
| 2018-09-30 | $-0.09 | $0.12 | x |
| 2019-09-30 | $-0.01 | $0.12 | x |
| 2020-09-30 | $-0.01 | $0.12 | x |
| 2021-09-30 | $0.05 | $0.12 | x |
| 2022-09-30 | $0.03 | $0.12 | x |
| 2023-09-30 | $0.03 | $0.12 | x |
| 2024-09-30 | $-4.11 | $0.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nukkleus Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -144.07%
- • Asset Turnover: 6.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-81.68%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -715.29% | -1141.67% | 0.53x | 1.18x | $-138.92K |
| 2014 | 0.00% | -48.82% | 7.98x | 0.00x | $-50.09K |
| 2015 | 0.00% | -139.14% | 0.00x | 0.00x | $-42.96K |
| 2016 | 0.00% | -2.68% | 8.24x | 0.00x | $-236.36K |
| 2017 | 0.00% | -0.57% | 21.72x | 0.00x | $-101.87K |
| 2018 | 0.00% | -1.10% | 62.79x | 0.00x | $-155.65K |
| 2019 | 0.00% | -3.80% | 94.58x | 0.00x | $-600.64K |
| 2020 | 0.00% | -0.53% | 5.05x | 0.00x | $38.42K |
| 2021 | -7.79% | -4.86% | 1.16x | 1.39x | $-2.14 Million |
| 2022 | -148.35% | -75.10% | 1.17x | 1.69x | $-17.25 Million |
| 2023 | -108.77% | -55.06% | 1.17x | 1.69x | $-12.93 Million |
| 2024 | 0.00% | -144.07% | 6.00x | 0.00x | $-7.81 Million |
Industry Comparison
This section compares Nukkleus Inc's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nukkleus Inc (NUKKW) | $-30.42 Million | -715.29% | N/A | $1.11K |
| Advent Technologies Holdings Inc (ADNWW) | $-1.79 Million | 0.00% | 0.00x | $26.11 |
| AmpliTech Group Inc (AMPGW) | $500.36K | -19.40% | 0.33x | $754.81 |
| Arko Corp (ARKOW) | $194.89 Million | -22.34% | 8.48x | $23.51 |
| Aris Mining Corporation (ARMN) | $216.71 Million | -1.53% | 1.14x | $3.93 Billion |
| Aberdeen Standard Global Infrastructure Income Fund (ASGI) | $482.92 Million | 1.71% | 0.01x | $472.62 Million |
| Atlas Corp (ATCOL) | $1.06 Billion | 13.71% | 2.46x | $240.21K |
| Auddia Inc (AUUDW) | $420.42K | -2094.93% | 9.47x | $398.90 |
| BriaCell Therapeutics Corp (BCTXW) | $-643.49K | 0.00% | 0.00x | $8.25 |
| Blaize Holdings, Inc. Warrants (BZAIW) | $24.24 Million | -252.48% | 0.99x | $4.00 Million |
| Churchill Capital Corp IX Warrant (CCIXW) | $288.99 Million | 3.04% | 0.04x | $14.04 Million |
About Nukkleus Inc
Nukkleus Inc., through its subsidiaries, engages primarily in the supply of generators for iron dome launchers and other defense products. It is also involved in the engineering, design, production, integration, sale, and maintenance of special tactical vehicles and trailers, including reconnaissance vehicles, mobile command and control vehicles, firefighting trailers, energy and lighting trailer… Read more